Can We Tame the Monster?
"Drug companies should not be allowed to evaluate their own products."
"Drug companies should not be allowed to evaluate their own products."
Dr. Trey Sunderland III, chief of the geriatric psychiatry branch at the National Institute of Mental Health, pled the Fifth amendment.
“There is a crisis of credibility in medicine and science,” says Dr Joseph Sonnabend who, as a former virologist for the Medical Research Council and a retired Aids physician, has watched the basis for public confidence decline.
An investigative report in The Philadelphia Inquirer examined pharmaceutical company ties to six, tax exempt organziations that identify themselves as “patient advocacy” groups, "Each a leading advocate for patients in a disease area.”
A front page article in The New York Times gives a ray of hope about reclaiming medicine from the clutches of industry and its single-minded profit-driven goals:
A documented report by David Armstrong of The Wall Street Journal (below) shatters the last glimmer of illusion about The New England Journal of Medicine as a bastion of scientific and moral integrity.
Congress is finally addressing a rip-off by scientists who redeive taxpayer money and don’t show their findings to the public.
The New York Times reports that former FDA Commissioner, Dr. Lester Crawford "is under criminalo investigation by a federal grand jury over accusations of financial improprieties and false statements to Congress."
APA "Diagnostic Statistical Manual" Task Force has been shown to have financial relationships with drug manufacturers.
The undisclosed financial relationships between drug manufacturers and psychiatry’s leading "authorities" who determine what constitutes a “mental disorder” have been exposed.
The Center for Public Integrity reports that FDA officials circumvent the prohibition on accepting trips from drug and medical device manufacturers.
The nation’s most powerful legislators have grown accustomed to riding in plush private coporate jets. How does that affect public policy?